🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementHypoglycemia risk with concomitant sulfonylurea use — 6 month update Page 2

Hypoglycemia risk with concomitant sulfonylurea use — 6 month update

PharmacoVig_BOS Sun, May 25, 2025 at 10:17 PM 15 replies 1,495 viewsPage 2 of 3
Dr.RaviCardio
VIP Member
2,890
15,678
Jan 2024
New York, NY
May 26, 2025 at 8:42 PM#6
mike.trainer_LA said:
The practical protocol is dull and it works: smaller meals, stop eating at the first sign of fullness rather than at the end of the plate, drop the…

I dislike how confidently this board tells people to push through. Incidence figures around 20 to 25% at the higher doses are class-typical, but the trials also had a discontinuation column, and "manageable with protocols" is not the same as manageable for everyone.

Happy to go further on any of that.

3 23pete_manc_UK, anna.melb_AU, mark_tokyo
Reply Quote Save Share Report
dan_philly
Member
456
2,123
Jul 2024
Philadelphia, PA
May 27, 2025 at 5:37 AM#7

One concrete data point for the thread. One practical note: write down what you did and when, before you need it. Reconstructing a timeline from memory three months later is how people end up unable to answer the one question that would have resolved it.

Last edited: May 27, 2025 at 8:37 AM
2 22AmyNC_wife, SkepticalSean
Reply Quote Save Share Report
DeniseRN_TPA
Member
345
1,567
Aug 2024
Tampa, FL
May 27, 2025 at 2:33 PM#8
Dr.RaviCardio said:
I dislike how confidently this board tells people to push through.

Adding the part of the answer the thread has not reached. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

That is the short version; the long version is somebody else's post.

1 21tommy_boulder
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
pete_RVA
Member
178
890
Dec 2024
Richmond, VA
May 27, 2025 at 11:29 PM#9

One thing that is still open after EndoResFellow’s answer:

Whether holding at a lower dose for longer actually reduces total side-effect burden or just spreads it out?

Last edited: May 28, 2025 at 4:29 AM
50 20MikeNYC_runner and 47 others
Reply Quote Save Share Report
PharmacoVig_BOS
Senior Member
1,567
8,901
Feb 2024
Boston, MA
May 29, 2025 at 6:22 PM#10

OP back with an update, since a thread like this is useless without one.

Holding the step for six weeks instead of four did it. Same dose, same food, and the nausea that had felt like a wall turned out to be a timing problem.

26 24LabKate, kate.chem, DataDave and 23 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register